Protein Supplementation: Body Composition, Muscle Strength and Postural Balance
Launched by UNIVERSITY OF SAO PAULO GENERAL HOSPITAL · Jan 2, 2019
Trial Information
Current as of July 24, 2025
Unknown status
Keywords
ClinConnect Summary
Eligibility Criteria:
Diabetes mellitus type 2 with stable dose of medication (oral antidiabetic or insulin or combination of both) for three months or more.
Glycated hemoglobin between 6 and 8.5% Renal function assessed by MDRD above 60 ml / h AST and ALT up to 2.5 times the upper limit of the No involvement of the musculoskeletal system with pain and any type of incapacitating disease or previous surgeries.
No chronic non-communicable disease not treated properly and decompensated Renal function assessed by MDRD equal to or above 60 ml / h
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Diabetes mellitus type 2 with stable dose of medication (oral antidiabetic or insulin or combination of both) for three months or more.
- • Glycated hemoglobin between 6 and 8.5%
- • Renal function assessed by MDRD above 60 ml / h
- • AST and ALT up to 2.5 times the upper limit of the
- • No involvement of the musculoskeletal system with pain and any type of incapacitating disease or previous surgeries.
- • No chronic non-communicable disease not treated properly and decompensated
- • Renal function assessed by MDRD equal to or above 60 ml / h
- Exclusion Criteria:
- • • Impossibility to conduct evaluation and training efficiently
About University Of Sao Paulo General Hospital
The University of São Paulo General Hospital (Hospital das Clínicas da Universidade de São Paulo) is a leading clinical research institution in Brazil, renowned for its commitment to advancing medical knowledge and patient care. As an academic hospital affiliated with one of the largest and most prestigious universities in Latin America, it integrates clinical practice, education, and research. The hospital conducts a wide array of clinical trials across various medical disciplines, aiming to develop innovative therapies and improve healthcare outcomes. With a multidisciplinary team of healthcare professionals and access to cutting-edge facilities, the University of São Paulo General Hospital is dedicated to fostering scientific advancements and addressing critical health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
São Paulo, , Brazil
Patients applied
Trial Officials
Julia C Greve, Professor
Principal Investigator
University of Sao Paulo
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials